Medtronic Revo MRI Pacer Approved, But Still Faces Reimbursement Hurdle

Medtronic is hoping that the immediate U.S. launch of its newly approved Revo MRI SureScan MRI-compatible pacemaker will help boost market share in the device category, but magnetic resonance imaging scans of implant recipients still face a key reimbursement hurdle.

More from Archive

More from Medtech Insight